Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis
- PMID: 32493508
- PMCID: PMC7268280
- DOI: 10.1186/s13075-020-02214-y
Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis
Abstract
Objectives: Skin fibrosis is a main hallmark of systemic sclerosis (SSc). Clinical assessment is done semi-quantitatively using the modified Rodnan skin score (mRSS). Objective measurements for quantifying skin fibrosis could complement the mRSS to achieve higher reproducibility. The aim of this study was to explore the potential of suction measurements to detect structural changes in the skin that are associated with skin fibrosis.
Methods: This clinical trial included 30 SSc patients and 30 healthy volunteers (HC). We validated a novel suction device-the Nimble-to quantify skin stiffness in comparison to the Cutometer using the OMERACT filter.
Results: A significant difference (p < 0.05) between the skin stiffness of HC and SSc patient groups was found for each location measured. The correlation between the measurements of forearm skin stiffness and the mRSS values was high for the Nimble (r = 0.82) and moderate for the Cutometer (r = 0.58). A ROC analysis showed good ability for the Nimble to distinguish between SSc patients with and without skin involvement (AUC = 0.82). Both suction devices provided excellent reliability in all measurements on HC and SSc patients and proved face validity and feasibility.
Conclusion: Suction devices assessing skin stiffness, such as the Nimble, show clear potential to objectively quantify skin fibrosis in SSc patients and might be promising outcome measures complementing established methods such as the mRSS.
Trial registration: Clinicaltrials.gov, NCT03644225, Registered 23 August 2018-Retrospectively registered, http://www.clinicaltrials.gov.
Keywords: Skin fibrosis; Skin stiffness; Suction measurement; Systemic sclerosis.
Conflict of interest statement
Prof. Dr. O. Distler had consultancy relationship and/or has received research funding from Abbvie, Actelion, Acceleron Pharma, Amgen, AnaMar, Baecon Discovery, Blade Therapeutics, Bayer, Boehringer Ingelheim, Catenion, Competitive Drug Development International Ltd., CSL Behring, ChemomAb, Curzion Pharmaceuticals, Ergonex, Galapagos NV, Glenmark Pharmaceuticals, GSK, Inventiva, Italfarmaco, iQone, iQvia, Lilly, medac, Medscape, Mitsubishi Tanabe Pharma, MSD, Novartis, Pfizer, Roche, Sanofi, Target Bio Science, and UCB in the area of potential treatments of scleroderma and its complications. In addition, Prof. Distler has a patent mir-29 for the treatment of systemic sclerosis issued (US8247389, EP2331143). Author Prof. Dr. Edoardo Mazza is coinventor of the related technology, described in the patent: Aspiration Device and Method for Determining Viscoelastic Properties of Biological Tissues and Synthetic Materials, EP16197195.7. The other authors declare that they have no competing interests.
Figures





Similar articles
-
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.Arthritis Res Ther. 2020 Mar 14;22(1):48. doi: 10.1186/s13075-020-2127-0. Arthritis Res Ther. 2020. PMID: 32171325 Free PMC article.
-
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosis.Arthritis Res Ther. 2025 Apr 11;27(1):85. doi: 10.1186/s13075-025-03508-9. Arthritis Res Ther. 2025. PMID: 40217251 Free PMC article.
-
Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.Int J Rheum Dis. 2019 Jun;22(6):1036-1040. doi: 10.1111/1756-185X.13523. Epub 2019 Mar 6. Int J Rheum Dis. 2019. PMID: 30838791 Free PMC article.
-
Efficacy of cyclophosphamide for skin fibrosis in systemic sclerosis: a systematic review and single-arm meta-analysis.Eur J Clin Pharmacol. 2025 Jun;81(6):863-874. doi: 10.1007/s00228-025-03837-3. Epub 2025 Apr 8. Eur J Clin Pharmacol. 2025. PMID: 40198334
-
High frequency ultrasonography: reliable tool to measure skin fibrosis in SSC? A systematic literature review and additional pilot study.Rheumatology (Oxford). 2021 Dec 24;61(1):42-52. doi: 10.1093/rheumatology/keab462. Rheumatology (Oxford). 2021. PMID: 34037710
Cited by
-
Intra- and inter-rater reliabilities of skin mechanical properties measured in healthy individuals using skin elasticity meter.Ann Med. 2023;55(2):2279747. doi: 10.1080/07853890.2023.2279747. Epub 2023 Nov 15. Ann Med. 2023. PMID: 37967233 Free PMC article.
-
Near-infrared spectroscopy-enabled electromechanical systems for fast mapping of biomechanics and subcutaneous diagnosis.Sci Adv. 2024 Nov 15;10(46):eadq9358. doi: 10.1126/sciadv.adq9358. Epub 2024 Nov 13. Sci Adv. 2024. PMID: 39536095 Free PMC article.
-
A quantitative comparison of devices for in vivo biomechanical characterization of human skin.Mech Soft Mater. 2023;5(1):5. doi: 10.1007/s42558-023-00053-w. Epub 2023 Jul 17. Mech Soft Mater. 2023. PMID: 37465029 Free PMC article.
-
Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation.Blood Adv. 2024 Sep 10;8(17):4651-4657. doi: 10.1182/bloodadvances.2024013233. Blood Adv. 2024. PMID: 38885484 Free PMC article.
-
Skin mechanical properties measured with skin elasticity measurement device in patients with lymphedema: Scoping review.Skin Res Technol. 2024 Aug;30(8):e13861. doi: 10.1111/srt.13861. Skin Res Technol. 2024. PMID: 39096185 Free PMC article.
References
-
- Zheng B, Nevskaya T, Baxter CA, Ramey DR, Pope JE, Baron M, et al. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology. 2019;59(2):398–406. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical